162 related articles for article (PubMed ID: 22396312)
1. Human prostate cancer initiating cells isolated directly from localized cancer do not form prostaspheres in primary culture.
Chen S; Principessa L; Isaacs JT
Prostate; 2012 Sep; 72(13):1478-89. PubMed ID: 22396312
[TBL] [Abstract][Full Text] [Related]
2. Cell-autonomous intracellular androgen receptor signaling drives the growth of human prostate cancer initiating cells.
Vander Griend DJ; D'Antonio J; Gurel B; Antony L; Demarzo AM; Isaacs JT
Prostate; 2010 Jan; 70(1):90-9. PubMed ID: 19790235
[TBL] [Abstract][Full Text] [Related]
3. Sphere culture of murine lung cancer cell lines are enriched with cancer initiating cells.
Morrison BJ; Steel JC; Morris JC
PLoS One; 2012; 7(11):e49752. PubMed ID: 23152931
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer stem-like cells/cancer-initiating cells have an autocrine system of hepatocyte growth factor.
Nishida S; Hirohashi Y; Torigoe T; Inoue R; Kitamura H; Tanaka T; Takahashi A; Asanuma H; Masumori N; Tsukamoto T; Sato N
Cancer Sci; 2013 Apr; 104(4):431-6. PubMed ID: 23320511
[TBL] [Abstract][Full Text] [Related]
5. In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue.
Guzmán-Ramírez N; Völler M; Wetterwald A; Germann M; Cross NA; Rentsch CA; Schalken J; Thalmann GN; Cecchini MG
Prostate; 2009 Nov; 69(15):1683-93. PubMed ID: 19644960
[TBL] [Abstract][Full Text] [Related]
6. Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance.
López J; Poitevin A; Mendoza-Martínez V; Pérez-Plasencia C; García-Carrancá A
BMC Cancer; 2012 Jan; 12():48. PubMed ID: 22284662
[TBL] [Abstract][Full Text] [Related]
7. Reduction of MHC-I expression limits T-lymphocyte-mediated killing of Cancer-initiating cells.
Morrison BJ; Steel JC; Morris JC
BMC Cancer; 2018 Apr; 18(1):469. PubMed ID: 29699516
[TBL] [Abstract][Full Text] [Related]
8. Targeting the cancer initiating cell: the Achilles' heel of cancer.
McCubrey JA; Chappell WH; Abrams SL; Franklin RA; Long JM; Sattler JA; Kempf CR; Laidler P; Steelman LS
Adv Enzyme Regul; 2011; 51(1):152-62. PubMed ID: 21035484
[TBL] [Abstract][Full Text] [Related]
9. Cancer-initiating cells from colorectal cancer patients escape from T cell-mediated immunosurveillance in vitro through membrane-bound IL-4.
Volonté A; Di Tomaso T; Spinelli M; Todaro M; Sanvito F; Albarello L; Bissolati M; Ghirardelli L; Orsenigo E; Ferrone S; Doglioni C; Stassi G; Dellabona P; Staudacher C; Parmiani G; Maccalli C
J Immunol; 2014 Jan; 192(1):523-32. PubMed ID: 24277698
[TBL] [Abstract][Full Text] [Related]
10. The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells.
Vander Griend DJ; Karthaus WL; Dalrymple S; Meeker A; DeMarzo AM; Isaacs JT
Cancer Res; 2008 Dec; 68(23):9703-11. PubMed ID: 19047148
[TBL] [Abstract][Full Text] [Related]
11. Identification and functional analysis of variants of a cancer/testis antigen LEMD1 in colorectal cancer stem-like cells.
Takeda R; Hirohashi Y; Shen M; Wang L; Ogawa T; Murai A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Nishidate T; Okita K; Kutomi G; Sato N; Takemasa I; Torigoe T
Biochem Biophys Res Commun; 2017 Apr; 485(3):651-657. PubMed ID: 28219643
[TBL] [Abstract][Full Text] [Related]
12. Clonal analysis revealed functional heterogeneity in cancer stem-like cell phenotypes in uterine endometrioid adenocarcinoma.
Tabuchi Y; Hirohashi Y; Hashimoto S; Mariya T; Asano T; Ikeo K; Kuroda T; Mizuuchi M; Murai A; Uno S; Kawai N; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Saito T; Torigoe T
Exp Mol Pathol; 2019 Feb; 106():78-88. PubMed ID: 30503404
[TBL] [Abstract][Full Text] [Related]
13. Genetically engineered oncolytic Newcastle disease virus mediates cytolysis of prostate cancer stem like cells.
Raghunath S; Pudupakam RS; Allen A; Biswas M; Sriranganathan N
J Biotechnol; 2017 Oct; 260():91-97. PubMed ID: 28935568
[TBL] [Abstract][Full Text] [Related]
14. LY6/PLAUR domain containing 3 has a role in the maintenance of colorectal cancer stem-like cells.
Wang L; Hirohashi Y; Ogawa T; Shen M; Takeda R; Murai A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Nishidate T; Okita K; Kutomi G; Sato N; Takemasa I; Torigoe T
Biochem Biophys Res Commun; 2017 Apr; 486(2):232-238. PubMed ID: 28238780
[TBL] [Abstract][Full Text] [Related]
15. Dysplasia of human prostate CD133(hi) sub-population in NOD-SCIDS is blocked by c-myc anti-sense.
Goodyear SM; Amatangelo MD; Stearns ME
Prostate; 2009 May; 69(7):689-98. PubMed ID: 19143028
[TBL] [Abstract][Full Text] [Related]
16. Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment.
Lagadec C; Vlashi E; Della Donna L; Meng Y; Dekmezian C; Kim K; Pajonk F
Breast Cancer Res; 2010; 12(1):R13. PubMed ID: 20158881
[TBL] [Abstract][Full Text] [Related]
17. WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics.
Bisson I; Prowse DM
Cell Res; 2009 Jun; 19(6):683-97. PubMed ID: 19365403
[TBL] [Abstract][Full Text] [Related]
18. Genomic analysis of prostate cancer stem cells isolated from a highly metastatic cell line.
Rowehl RA; Crawford H; Dufour A; Ju J; Botchkina GI
Cancer Genomics Proteomics; 2008; 5(6):301-10. PubMed ID: 19287071
[TBL] [Abstract][Full Text] [Related]
19. CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer.
Chen YS; Wu MJ; Huang CY; Lin SC; Chuang TH; Yu CC; Lo JF
PLoS One; 2011; 6(11):e28053. PubMed ID: 22140506
[TBL] [Abstract][Full Text] [Related]
20. Targeting the cancer initiating cell: the ultimate target for cancer therapy.
McCubrey JA; Steelman LS; Abrams SL; Misaghian N; Chappell WH; Basecke J; Nicoletti F; Libra M; Ligresti G; Stivala F; Maksimovic-Ivanic D; Mijatovic S; Montalto G; Cervello M; Laidler P; Bonati A; Evangelisti C; Cocco L; Martelli AM
Curr Pharm Des; 2012; 18(13):1784-95. PubMed ID: 22394167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
